Search results
Q2 2024 EPS Estimates for The Travelers Companies, Inc. (NYSE:TRV) Boosted by Zacks Research
ETF DAILY NEWS· 5 days agoThe consensus estimate for Travelers Companies’ current full-year earnings is $17.86 per share. ...
FOCUS Wealth Advisors LLC Buys New Shares in JPMorgan Chase & Co. (NYSE:JPM)
ETF DAILY NEWS· 12 hours agoFOCUS Wealth Advisors LLC bought a new position in shares of JPMorgan Chase & Co. (NYSE:JPM – Free...
Fulton Bank N.A. Sells 400 Shares of Weyerhaeuser (NYSE:WY)
ETF DAILY NEWS· 20 hours agoFulton Bank N.A. trimmed its position in Weyerhaeuser (NYSE:WY – Free Report) by 6.0% during the...
Royal London Asset Management Ltd. Acquires Shares of 2,201 Westlake Co. (NYSE:WLK)
ETF DAILY NEWS· 7 days agoRoyal London Asset Management Ltd. bought a new position in shares of Westlake Co. (NYSE:WLK – Free...
Samsara stock: BofA initiates coverage with a Buy rating and $37 target | Invezz
Invezz· 3 days agoThis comes as Samsara continues to carve out a niche in the rapidly evolving field of AI-driven auto...
Canada Population Surpasses 41 Million, Fueled by Immigration - Update
Morningstar· 5 days agoOTTAWA--Canada's population surpassed the 41-million person mark in the first quarter, with nearly all of the robust on-year growth powered by immigration. Economists say ...
Brokerages Set Addus HomeCare Co. (NASDAQ:ADUS) Price Target at $112.14
ETF DAILY NEWS· 6 days agoOne investment analyst has rated the stock with a sell rating and seven have issued a buy rating on the company. The average twelve-month price target among brokerages that ...
Desjardins Reiterates “C$38.00” Price Target for Empire (TSE:EMP.A)
ETF DAILY NEWS· 5 days agoDesjardins set a C$38.00 price objective on Empire (TSE:EMP.A – Free Report) in a research note released on Tuesday morning, BayStreet.CA reports. The brokerage currently has a buy rating on ...
Cantor Fitzgerald Reiterates “Overweight” Rating for Perspective Therapeutics (NYSE:CATX)
ETF DAILY NEWS· 4 days agoRoyal Bank of Canada reiterated an “outperform” rating and issued a $30.00 price objective on shares...
Agios Pharmaceuticals (NASDAQ:AGIO) Trading Up 4%
ETF DAILY NEWS· 22 hours agoCantor Fitzgerald reaffirmed an “overweight” rating on shares of Agios Pharmaceuticals in a research note on Monday, June 17th. Royal Bank of Canada ...